Skip to content
DilutionScan
Zhengye Biotechnology Holding Ltd logo
ZYBT$1.30-2.26%

Zhengye Biotechnology Holding Ltd

Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: CNExchange: Nasdaq

Mkt Cap$61.61M
Float & O/S
Inst Own

DilutionScan read 20 of Zhengye Biotechnology Holding Ltd's SEC filings and found 1 S-1 registration on file for ZYBT. The latest dilution event on file is a registration statement on Jan 9, 2024. Analysis updated Oct 12, 2026.

Signal8 Summary

ZYBT

Shrinking revenue, Nasdaq bid-price scare

Snapshot

Zhengye is a tiny Chinese veterinary vaccine maker whose business shrank sharply: FY 2025 revenue fell 37.6% to $17.4M, and gross margin dropped to 20.5% from 49% the prior year.

What's Happening Right Now

  • : Zhengye regained compliance with Nasdaq's $1.00 minimum bid price requirement on Aug 5, 2026, after trading below $1 for 30 straight days earlier in the year; the company remains listed under ZYBT ahead of a Nov 25, 2026 deadline.
  • : After unusual swings in its share price and volume, Zhengye said on Jul 29, 2026 it has no undisclosed material news that explains the activity and is cooperating with Nasdaq on the volume increase.
  • : On Jul 21, 2026, Zhengye issued a statement addressing unusual trading activity in its shares, noting it does not normally comment on market rumors.

Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 1029 days ago

Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need

AI dilution summary

The dominant contractual driver and its mechanism, then each further driver ranked.

Latest dilution event

Jan 9, 2024 · Registration

How we read filings

Every warrant, convertible, ATM and shelf, cited to the filing

A free account reads 3 tickers a day in full

Get Pro · every ticker

$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)

Share count and cash history

Shares outstanding, potential dilution and cash over time

S-1 · 1

What is this?

Size, shares registered and dates with Pro

S-1 · primary offering

Issued 2024

Completed

Proposed maximum

Shares registered

Filed
Effective
Filing link and full terms

Know who's about to sell into your ZYBT trade

Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.

Get Pro · every ticker

$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)

DilutionScan ProEvery instrument in full · $59/mo